Comments

Checkpoint Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Checkpoint Therapeutics (CKPT) operate in?

Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CKPTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.63

0.062.53%

At close: -

$2.61

-0.02-0.76%

After Hours: 5:40 PM EDT

Checkpoint Therapeutics (CKPT) Forecast

News Earnings Checkpoint Therapeutics (CKPT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Checkpoint Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CKPT | Benzinga

Explore Checkpoint Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CKPT.

Open	$2.50
Close	$2.63
Volume / Avg.	668.30K / 1.31M
Day Range	$2.43 - $2.68
52 Wk Range	1.38 - 4.50
Market Cap	$127.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	16.49%
Days to Cover	7.99

Recent News

This PG&E Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection

Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.

Vandana Singh

US Stocks To Open Higher Ahead Of Fed's Decision This Week: Analyst Says 'Santa Comes Later In December'

U.S. stock futures were trading higher after the Nasdaq 100 extended its relentless climb last week, nearing the 22,000-point milestone.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.50
Close	$2.63
Volume / Avg.	668.30K / 1.31M
Day Range	$2.43 - $2.68
52 Wk Range	1.38 - 4.50
Market Cap	$127.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	16.49%
Days to Cover	7.99

About Checkpoint Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It foc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Checkpoint Therapeutics (CKPT) stock?

You can purchase shares of Checkpoint Therapeutics (NASDAQ:CKPT) through any online brokerage.

View our list of the best stock brokerages

Who are Checkpoint Therapeutics (CKPT) competitors?

Other companies in Checkpoint Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).

What is the forecast, or price target, for Checkpoint Therapeutics (CKPT) stock?

Checkpoint Therapeutics has a consensus price target of $24.29.

What is the current price for Checkpoint Therapeutics (CKPT)?

The stock price for Checkpoint Therapeutics (NASDAQ: CKPT) is $2.61 last updated March 4, 2025 at 5:40 PM EST.

Does Checkpoint Therapeutics (CKPT) pay a dividend?

There are no upcoming dividends for Checkpoint Therapeutics.

When is Checkpoint Therapeutics (NASDAQ:CKPT) reporting earnings?

Checkpoint Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Checkpoint Therapeutics (CKPT) going to split?

There is no upcoming split for Checkpoint Therapeutics.

What sector and industry does Checkpoint Therapeutics (CKPT) operate in?

Checkpoint Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.